Surgery PartnersSGRY
SGRY
About: Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Employees: 13,500
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
300% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 4 (+3) [Q3]
31% more capital invested
Capital invested by funds: $3.39B [Q2] → $4.42B (+$1.03B) [Q3]
13% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 32
12% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 60
2% more funds holding
Funds holding: 179 [Q2] → 183 (+4) [Q3]
4.14% less ownership
Funds ownership: 112.0% [Q2] → 107.86% (-4.14%) [Q3]
67% less call options, than puts
Call options by funds: $5.04M | Put options by funds: $15.4M
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$28
32%
upside
Avg. target
$36
68%
upside
High target
$43
103%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
JP Morgan Lisa Gill 35% 1-year accuracy 7 / 20 met price target | 32%upside $28 | Neutral Maintained | 3 Dec 2024 |
RBC Capital Ben Hendrix 25% 1-year accuracy 18 / 71 met price target | 65%upside $35 | Outperform Maintained | 20 Nov 2024 |
Macquarie Tao Qiu 33% 1-year accuracy 5 / 15 met price target | 60%upside $34 | Outperform Maintained | 19 Nov 2024 |
UBS A.J. Rice 41% 1-year accuracy 7 / 17 met price target | 79%upside $38 | Buy Initiated | 14 Oct 2024 |
Cantor Fitzgerald Sarah James 23% 1-year accuracy 30 / 130 met price target | 103%upside $43 | Overweight Reiterated | 4 Oct 2024 |
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript
Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzgerald Bill Sutherland - The Benchmark Company Benjamin Rossi - JPMorgan Will Spivack - TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call.
Negative
Zacks Investment Research
1 month ago
Surgery Partners (SGRY) Misses Q3 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.19 per share a year ago.
Neutral
Zacks Investment Research
1 month ago
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
GlobeNewsWire
2 months ago
Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2024 results before the market opens on Tuesday, November 12, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time).
Positive
Benzinga
2 months ago
Here's Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company.
Neutral
MarketBeat
2 months ago
Here's Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company.
Neutral
Business Wire
4 months ago
Sheridan Capital Partners-Backed Oral Surgery Partners Announces Appointment of New CEO
CHICAGO--(BUSINESS WIRE)--Oral Surgery Partners (“OSP”), an established oral surgery management group, is pleased to announce the appointment of Sohail Malad as its new Chief Executive Officer, effective August 12th. Sohail Malad, a seasoned healthcare executive with a proven track record of leadership and innovation, will succeed John Cline, who served as CEO for the past three years and will continue to remain involved in an advisory capacity. Under John's tenure, OSP experienced significant.
Positive
Zacks Investment Research
4 months ago
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.
Neutral
GlobeNewsWire
4 months ago
Surgery Partners, Inc. Announces Second Quarter 2024 Results Raises Full Year 2024 Guidance
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024.
Neutral
Zacks Investment Research
4 months ago
SGRY or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Surgery Partners (SGRY) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Charts implemented using Lightweight Charts™